If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Mounjaro™ (tirzepatide) injection2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Tirzepatide: Comparison With Once-Weekly Semaglutide 2 mg
Tirzepatide compared with semaglutide 2 mg has not been studied.
Lilly has not conducted and are not currently conducting clinical studies comparing tirzepatide with once-weekly semaglutide 2 mg.2
1A study of tirzepatide (LY3298176) versus semaglutide once weekly as add-on therapy to metformin in participants with type 2 diabetes (SURPASS-2). ClinicalTrials.gov identifier: NCT03987919. Updated March 11, 2021. Accessed March 23, 2021. https://clinicaltrials.gov/ct2/show/NCT03987919
2Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Lilly = Eli Lilly and Company
Date of Last Review: March 23, 2021